首页> 美国卫生研究院文献>Materials >Efficacy of Enamel Derivatives to Improve Keratinized Tissue as Adjunct to Coverage of Gingival Recessions: A Systematic Review and Meta-Analysis
【2h】

Efficacy of Enamel Derivatives to Improve Keratinized Tissue as Adjunct to Coverage of Gingival Recessions: A Systematic Review and Meta-Analysis

机译:牙釉质衍生物改善角质化组织作为覆盖牙龈退缩的功效:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: The systematic review was designed to answer the following focused question: Are enamel matrix derivatives able to improve the quantity of keratinized tissue (KT) around natural dentition in patients with recessions defects after their treatment with periodontal plastic procedures? Methods: Only Randomized Clinical Trials (RCT) in English language evaluating root coverage procedures in combination with enamel matrix derivatives (commercially known as Emdogain®—EMD), with at least 10 subjects and a minimum duration of six months, were included. The search was applied to PUBMED and SCOPUS and it consists of a combination of MeSH terms and free text words (from January 2000 to June 2019). Risk of bias in individual studies and across studies was also evaluated. Results: After the full text analysis and the exclusion of further 18 articles, 12 articles were finally included. In total 639 recessions were treated (334 tests and 305 control). The recessions defects were classified according to the classification of Miller (Class I, II, III, IV). Only one trial included Miller Class III recessions (7 in total). Enamel matrix derivatives were applied in conjunction with Coronally Advanced Flap (CAF), Coronally Advanced Flap + Sub Epithelial Connective Tissue Graft (CAF + CTG), Semilunar Flap (SF). For the group CAF vs CAF + EMD the mean difference between the keratinized tissue gain in the two procedures was 0.40 mm (95% Confindence Interval Lower/Upper: 0.014–0.81) (p < 0.058); for the comparison CAF + CTG + EMD vs. CAF + CTG the mean difference between the two groups resulted in −0.06 mm (95% Confindence Interval Lower Upper −0.45 to 0.33) (p = 0.7603). Discussion: Randomized clinical trials included medium-low quality evidence. The application of Enamel Matrix Derivatives to surgical procedures aimed to cover gingival recessions does not add robust clinical benefit to conventional plastic procedure alone.
机译:背景:系统评价旨在回答以下重点问题:牙周整形治疗后的凹陷缺陷患者,牙釉质基质衍生物是否能够改善自然牙列周围的角化组织(KT)量?方法:只有英语语言的随机临床试验(RCT)结合牙釉质基质衍生物(商业上称为Emdogain ® -EMD)评估牙根覆盖程序,至少10名受试者,最少持续6个疗程个月,包括在内。该搜索适用于PUBMED和SCOPUS,它由MeSH术语和自由文本组成(2000年1月至2019年6月)。还评估了个体研究和跨研究的偏倚风险。结果:经过全文分析并排除另外18篇文章,最终包括12篇文章。总共处理了639次衰退(334次测试和305次对照)。根据Miller的分类(I,II,III,IV类)对凹陷缺陷进行分类。只有一项试验包括Miller III类衰退(总共7项)。搪瓷基质衍生物与冠状高级皮瓣(CAF),冠状高级皮瓣+上皮下结缔组织移植物(CAF + CTG),半月皮瓣(SF)结合使用。对于CAF vs CAF + EMD组,两次手术中角质化组织增益之间的平均差为0.40 mm(95%置信区间上下限:0.014–0.81)(p <0.058);对于CAF + CTG + EMD与CAF + CTG的比较,两组之间的平均差为-0.06毫米(95%置信区间下上限-0.45至0.33)(p = 0.7603)。讨论:随机临床试验包括中低质量证据。搪瓷基体衍生物在旨在覆盖牙龈退缩的外科手术中的应用并没有给常规的整形手术带来强大的临床益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号